Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$4.52B |
| 2 |
Intel
INTC
|
$2.2B |
| 3 |
Union Pacific
UNP
|
$1.08B |
| 4 |
Norfolk Southern
NSC
|
$889M |
| 5 |
Wells Fargo
WFC
|
$796M |
Top Sells
| 1 |
Amazon
AMZN
|
$812M |
| 2 |
Johnson Controls International
JCI
|
$791M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
$618M |
| 4 |
Altria Group
MO
|
$589M |
| 5 |
Intuit
INTU
|
$537M |
Sector Composition
| 1 | Healthcare | 22.14% |
| 2 | Technology | 12.08% |
| 3 | Industrials | 11.21% |
| 4 | Communication Services | 11.1% |
| 5 | Consumer Discretionary | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amgen
AMGN
$155B
| $14.3B | 4.7% | 93,139,648 -42,427 | -0% | -$6.51M |
|
2
Gilead Sciences
GILD
$140B
| $11.7B | 3.85% | 99,991,520 -977,740 | -1% | -$114M |
|
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $8.29B | 2.72% | 15,654,652 +8,533,959 | +120% | +$4.52B |
|
4
Verizon
VZ
$186B
| $8.17B | 2.68% | 175,249,677 +3,262,000 | +2% | +$152M |
|
|
5
Amazon
AMZN
$2.44T
| $6.43B | 2.11% | 14,817,635 -1,870,800 | -11% | -$812M |
|
6
Philip Morris
PM
$260B
| $6.26B | 2.06% | 78,109,313 -4,205,360 | -5% | -$337M |
|
7
Oracle
ORCL
$635B
| $5.97B | 1.96% | 148,135,118 +12,064,000 | +9% | +$486M |
|
8
AbbVie
ABBV
$372B
| $5.57B | 1.83% | 82,969,218 -7,484,916 | -8% | -$503M |
|
9
Texas Instruments
TXN
$184B
| $4.96B | 1.63% | 96,196,948 -4,335,844 | -4% | -$223M |
|
|
10
Altria Group
MO
$113B
| $4.91B | 1.61% | 100,366,416 -12,037,187 | -11% | -$589M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.76B | 1.56% | 26,333,741 +1,570,549 | +6% | +$284M |
|
12
Netflix
NFLX
$513B
| $4.29B | 1.41% | 6,537,532 -648,561 | -9% | -$426M |
|
13
General Dynamics
GD
$87.3B
| $3.54B | 1.16% | 24,996,204 +468,332 | +2% | +$66.4M |
|
|
PCP
14
DELISTED
PRECISION CASTPARTS CORP
PCP
| $3.47B | 1.14% | 17,366,540 | – | – |
|
|
15
Union Pacific
UNP
$133B
| $3.42B | 1.12% | 35,846,522 +11,299,260 | +46% | +$1.08B |
|
16
Home Depot
HD
$405B
| $3.28B | 1.08% | 29,511,621 -608,200 | -2% | -$67.6M |
|
17
UnitedHealth
UNH
$281B
| $3.24B | 1.07% | 26,580,463 -675,486 | -2% | -$82.4M |
|
18
Accenture
ACN
$162B
| $3.18B | 1.05% | 32,858,903 -2,174,300 | -6% | -$210M |
|
19
AT&T
T
$209B
| $3.02B | 0.99% | 84,910,073 +775,000 | +0.9% | +$27.5M |
|
20
Stryker
SYK
$150B
| $3B | 0.98% | 31,359,233 +3,360,000 | +12% | +$321M |
|
21
Crown Castle
CCI
$43.2B
| $2.93B | 0.96% | 36,462,436 +3,911,300 | +12% | +$314M |
|
|
22
Intel
INTC
$107B
| $2.75B | 0.9% | 90,408,500 +72,268,500 | +398% | +$2.2B |
|
23
CSX Corp
CSX
$60.6B
| $2.72B | 0.9% | 83,417,302 +2,907,000 | +4% | +$94.9M |
|
24
BioMarin Pharmaceuticals
BMRN
$11.2B
| $2.69B | 0.88% | 19,637,821 +143,705 | +0.7% | +$19.7M |
|
25
Canadian Natural Resources
CNQ
$65.9B
| $2.68B | 0.88% | 98,863,845 +11,701,590 | +13% | +$318M |
|